This is the new MLex platform. Existing customers should continue to use the existing MLex platform until migrated.
For any queries, please contact Customer Services or your Account Manager. Dismiss

LloydsPharmacy-McCabes deal wins conditional Irish approval

( April 26, 2024, 13:58 GMT | Official Statement) -- MLex Summary: Pharmacy operator LloydsPharmacy has obtained conditional green light to buy rival McCabes Pharmacy, the Irish competition authority said today. LloydsPharmacy agreed to sell two pharmacies in Lucan, Dublin, to a buyer to be approved by the authority. It also obliged to not to anything that could negatively affect the pharmacies before their sale and not to buy them back for a period of at least ten years, the authority said. The transaction was re-notified in February, after the first notification was declared invalid last year.Statement follows. ...

Prepare for tomorrow’s regulatory change, today

MLex identifies risk to business wherever it emerges, with specialist reporters across the globe providing exclusive news and deep-dive analysis on the proposals, probes, enforcement actions and rulings that matter to your organization and clients, now and in the longer term.


Know what others in the room don’t, with features including:

  • Daily newsletters for Antitrust, M&A, Trade, Data Privacy & Security, Technology, AI and more
  • Custom alerts on specific filters including geographies, industries, topics and companies to suit your practice needs
  • Predictive analysis from expert journalists across North America, the UK and Europe, Latin America and Asia-Pacific
  • Curated case files bringing together news, analysis and source documents in a single timeline

Experience MLex today with a 14-day free trial.

Start Free Trial

Already a subscriber? Click here to login